Literature DB >> 23294025

Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis.

K K Shah1, S D O'Dell.   

Abstract

BACKGROUND: Untreated glycogen storage disease (GSD)-1a patients experience hypoglycaemia and growth retardation. The present study examined the effects of dietary interventions on the maintenance of normoglycaemia.
METHODS: Clinical trials were identified from EMBASE (January 1980 to November 2011), MEDLINE (January 1948 to November 2011) and the Cochrane Central Register of Controlled Trials (2011, Issue 4). The intermittent administration of uncooked cornstarch was compared with: (i) continuous nocturnal feeding of dextrose; (ii) modified uncooked cornstarch; and (iii) dextrose and an uncooked cornstarch-dextrose mixture. One author extracted the data, and assessed the trial eligibility and risk of bias. Quality assessment and data extraction were conducted and checked independently.
RESULTS: Of 41 articles retrieved, five controlled trials (49 participants) were identified with follow-up at 2 days to 14 years. Results from three nonrandomised controlled trials comparing uncooked cornstarch with continuous nocturnal feeding of dextrose were pooled in a meta-analysis based on a fixed-effect model. Twenty-six participants (three trials) receiving uncooked cornstarch showed a significant increase in blood glucose concentration: mean difference (MD) 0.62 mmol L(-1) [95% confidence interval (CI) = 0.23-1.00] (P = 0.002), 21 (two trials) increased serum insulin: MD 62.37 pmol L(-1) (95% CI = 32.19-92.55) (P < 0.0001) and 22 (three trials) increased plasma total cholesterol: MD 0.68 mmol L(-1) (95% CI = 0.17- 1.20) (P = 0.01) compared to continuous nocturnal feeding of dextrose. Twenty-eight subjects (three trials) showed decreased plasma lactate after nocturnal feeding: MD -0.42 mmol L(-1) (95% CI = -0.58 to -0.25) (P < 0.00001).
CONCLUSIONS: Short- to long-term overnight intermittent administration of uncooked cornstarch prevents nocturnal hypoglycaemia in GSD-1a children more effectively than continuous nocturnal feeding of dextrose.
© 2013 The Authors Journal of Human Nutrition and Dietetics © 2013 The British Dietetic Association Ltd.

Entities:  

Keywords:  clinical nutrition; dietary intervention; metabolic disorders; systematic review

Mesh:

Substances:

Year:  2013        PMID: 23294025     DOI: 10.1111/jhn.12030

Source DB:  PubMed          Journal:  J Hum Nutr Diet        ISSN: 0952-3871            Impact factor:   3.089


  16 in total

Review 1.  Defining 'nutraceuticals': neither nutritious nor pharmaceutical.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2016-04-25       Impact factor: 4.335

2.  Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study.

Authors:  Michel Hochuli; Emanuel Christ; Fabian Meienberg; Roger Lehmann; Jan Krützfeldt; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2015-06-25       Impact factor: 4.982

Review 3.  Inherited Metabolic Disorders: Aspects of Chronic Nutrition Management.

Authors:  Suzanne W Boyer; Lisa J Barclay; Lindsay C Burrage
Journal:  Nutr Clin Pract       Date:  2015-06-16       Impact factor: 3.080

Review 4.  Studies on glycogen storage disease type 1a animal models: a brief perspective.

Authors:  Irina O Petrova; Svetlana A Smirnikhina
Journal:  Transgenic Res       Date:  2022-08-25       Impact factor: 3.145

5.  Development of minimally invasive 13C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia.

Authors:  Abrar Turki; Sylvia Stockler; Sandra Sirrs; Ramona Salvarinova; Gloria Ho; Jennifer Branov; Annie Rosen-Heath; Taryn Bosdet; Rajavel Elango
Journal:  Mol Genet Metab Rep       Date:  2022-05-11

Review 6.  Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  J Inherit Metab Dis       Date:  2014-10-07       Impact factor: 4.982

7.  mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease.

Authors:  Jingsong Cao; Minjung Choi; Eleonora Guadagnin; Maud Soty; Marine Silva; Vincent Verzieux; Edward Weisser; Arianna Markel; Jenny Zhuo; Shi Liang; Ling Yin; Andrea Frassetto; Anne-Renee Graham; Kristine Burke; Tatiana Ketova; Cosmin Mihai; Zach Zalinger; Becca Levy; Gilles Besin; Meredith Wolfrom; Barbara Tran; Christopher Tunkey; Erik Owen; Joe Sarkis; Athanasios Dousis; Vladimir Presnyak; Christopher Pepin; Wei Zheng; Lei Ci; Marjie Hard; Edward Miracco; Lisa Rice; Vi Nguyen; Mike Zimmer; Uma Rajarajacholan; Patrick F Finn; Gilles Mithieux; Fabienne Rajas; Paolo G V Martini; Paloma H Giangrande
Journal:  Nat Commun       Date:  2021-05-25       Impact factor: 14.919

8.  Hepatic Glycogenoses Among Children-Clinical and Biochemical Characterization: Single-Center Study.

Authors:  Sophy Korula; Sumita Danda; Praveen G Paul; Sarah Mathai; Anna Simon
Journal:  J Clin Exp Hepatol       Date:  2019-07-25

9.  A pilot longitudinal study of the use of waxy maize heat modified starch in the treatment of adults with glycogen storage disease type I: a randomized double-blind cross-over study.

Authors:  Kaustuv Bhattacharya; Helen Mundy; Maggie F Lilburn; Michael P Champion; David W Morley; François Maillot
Journal:  Orphanet J Rare Dis       Date:  2015-02-15       Impact factor: 4.123

Review 10.  Glycogen metabolism in humans.

Authors:  María M Adeva-Andany; Manuel González-Lucán; Cristóbal Donapetry-García; Carlos Fernández-Fernández; Eva Ameneiros-Rodríguez
Journal:  BBA Clin       Date:  2016-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.